Assessing hepatotoxicity in novel and standard short regimens for rifampicin-resistant tuberculosis: Insights from the TB-TRUST and TB-TRUST-plus trials

Objectives: Efforts to shorten rifampicin-resistant tuberculosis (RR-TB) treatment have led to concerns about hepatotoxicity in shorter regimens. We evaluated hepatotoxicity in two novel regimens against the standard shorter regimen recommended by the World Health Organization (WHO). Methods: Partic...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Lingyun Song, Yilin Zhang, Feng Sun, Yuanbo Lan, Jie Tong, Shijia Ge, Zhen Feng, Rong Li, Hongying Yu, Yang Li, Wenhong Zhang
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2024-11-01
Saila:	International Journal of Infectious Diseases
Gaiak:	Rifampicin-resistant tuberculosis Antitubercular agents Hepatotoxicity Drug-induced liver injury
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S1201971224003011
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!